This book presents original research results on the leading edge of cancer. Topics discussed include one woman's experience with the Gerson therapy for cancer; epigenetic upregulation or direct over-expression of miR-137 enhances anti-tumour activity of delphinidin for inducing apoptosis in human glioblastoma T98G cells; potentials and challenges of chip technologies in serum biomarker studies for personalised medicine of colorectal cancer; colon cancer; targeting hallmarks of cancer as current therapeutic strategy; and epigenetic regulation of cancer.